- Home
- PCVX vs GBCI Comparison
PCVX vs GBCI Comparison
Compare PCVX & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | GBCI |
|---|---|---|
| Founded | 2013 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | GBCI |
|---|---|---|
| Price | $47.53 | $46.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $105.00 | $53.60 |
| AVG Volume (30 Days) | ★ 1.2M | 870.5K |
| Earning Date | 02-24-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 26.70 |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $900,148,000.00 |
| Revenue This Year | N/A | $13.72 |
| Revenue Next Year | N/A | $27.55 |
| P/E Ratio | ★ N/A | $22.43 |
| Revenue Growth | N/A | ★ 15.35 |
| 52 Week Low | $27.66 | $36.76 |
| 52 Week High | $93.77 | $52.81 |
Technical Indicators
Market Signals| Indicator | PCVX | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 59.10 | 60.10 |
| Support Level | $44.57 | $45.94 |
| Resistance Level | $47.72 | $48.15 |
| Average True Range (ATR) | 2.00 | 1.16 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 75.11 | 77.04 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About GBCI Glacier Bancorp Inc.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.